5-Fluorouracil and mitomycin-C: Effective, low-cost chemotherapy for colorectal cancer

Journal of the Medical Association of Thailand

Volumn 89, Issue 11, 2006, Pages 1885-1889

  Aphinives, Potchavit ^a   Bhudhisawasdi, Vajarabhongsa ^a   Sae seow, Otur ^a   Uttaravichien, Thongueb ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

5 fluorouracil; Colorectal cancer; Mitomycin C

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG TOLERABILITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; TUMOR DIFFERENTIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33845490651     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Waters J, Cunninghan D. The changing face of chemotherapy in colorectal cancer. Br J Cancer 2001; 84: 1-7.
2. Ross P, Norman A, Cunningham D, Webb A, Iveson T, Padhani A, et al. A prospective randomized trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol 1997; 8: 995-1001.
3. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
4. Andr□ T, Louvet C, Maindrault-Goebel F, Couteau C, Mabro M, Lotz JP, et al. CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. Eur J Cancer 1999; 35: 1343-7.
5. Hansen RM, Ryan L, Anderson T, Krzywda B, Quebbeman E, Benson A III, et al. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer. J Natl Cancer Inst 1996; 88: 668-74.
6. Mackintosh J, Coates A, Swanson C, Raghavan D, Tattersall MHN. Chemotherapy of advanced colorectal cancer: a randomized trial of sequential methotrexate and 5-fluorouracil. Am J Clin Oncol 1987; 10: 210-2.
7. Sobrero A, Guglielmi A, Cirillo M, Recaldin E, Frassineti GL, Aschele C, et al. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer. Br J Cancer 2001; 84: 1023-8.
8. Kikuchi K, Kunii Y, Kunitomo K. Treatment with UFT as surgical adjuvant chemotherapy in carcinoma of large intestine. Jpn J Cancer Chemotherapy 1990; 17: 663-70.
9. Kodaira S, Kikuchi K, Inokuchi K, Komi N, Hattori T, Taguchi T, et al. Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma: a preliminary report. Jpn J Cancer Chemotherapy 1989; 16: 3399-408.
10. Toge T. Progress of adjuvant chemotherapy in colon cancer. Jpn J Cancer Chemotherapy 1996; 23: 554-9.
11. Hojyo K, Kajitani K. Adjuvant chemotherapy for colorectal cancer. Results of prospective randomized trials. Jpn J Cancer Chemotherapy 1986; 13: 3063-73.
12. Watanabe H, Sakakibara N. Evaluation of longterm administration of oral anticancer agent. Jpn J Cancer Chemotherapy 1993; 20: 637-42.